Pancreatic cancer remains a devastating and poorly understood malignancy and represents a major therapeutic challenge in 2008.
The annual incidence rate of pancreatic cancer is almost identical to the mortality rate; approximately 37,000 new cases are diagnosed each year in the United States, and approximately 33,000 patients die from this disease. Poor prognosis has been attributed [...]